Journal: Environmental Health and Preventive Medicine

Article Title: Association between lifestyle habits and bone mineral density in Japanese juveniles

doi: 10.1007/s12199-009-0131-8

Figure Lengend Snippet: Multiple linear regression analysis with bone mineral density (BMD) as the dependent variable, and sex, calendar age, body mass index (BMI), and grip strength as independent variables

Article Snippet: BMD measurement BMD was measured by DXA at the distal forearm of the nondominant side (DTX-200; Osteometer MediTech Inc., CA, USA), as previously described [ 9 ].

Techniques:

Journal: Environmental Health and Preventive Medicine

Article Title: Association between lifestyle habits and bone mineral density in Japanese juveniles

doi: 10.1007/s12199-009-0131-8

Figure Lengend Snippet: The relationship between secondary sexual characteristics and bone mineral density (BMD). a Comparison of BMD between the “before change in voice” and “after change in voice” groups in boys. b Comparison of BMD between the “before menarche” and “after menarche” groups in girls. *p < 0.05, **p < 0.01

Article Snippet: BMD measurement BMD was measured by DXA at the distal forearm of the nondominant side (DTX-200; Osteometer MediTech Inc., CA, USA), as previously described [ 9 ].

Techniques: Comparison

Journal: Environmental Health and Preventive Medicine

Article Title: Association between lifestyle habits and bone mineral density in Japanese juveniles

doi: 10.1007/s12199-009-0131-8

Figure Lengend Snippet: Correlation between milk consumption and bone mineral density (BMD)

Article Snippet: BMD measurement BMD was measured by DXA at the distal forearm of the nondominant side (DTX-200; Osteometer MediTech Inc., CA, USA), as previously described [ 9 ].

Techniques:

Journal: Environmental Health and Preventive Medicine

Article Title: Association between lifestyle habits and bone mineral density in Japanese juveniles

doi: 10.1007/s12199-009-0131-8

Figure Lengend Snippet: Multiple linear regression analysis of bone mineral density (BMD) with intake of nutritional elements

Article Snippet: BMD measurement BMD was measured by DXA at the distal forearm of the nondominant side (DTX-200; Osteometer MediTech Inc., CA, USA), as previously described [ 9 ].

Techniques:

Journal: Environmental Health and Preventive Medicine

Article Title: Association between lifestyle habits and bone mineral density in Japanese juveniles

doi: 10.1007/s12199-009-0131-8

Figure Lengend Snippet: Multiple linear regression analysis of bone mineral density (BMD) with lifestyle and history of bone fracture

Article Snippet: BMD measurement BMD was measured by DXA at the distal forearm of the nondominant side (DTX-200; Osteometer MediTech Inc., CA, USA), as previously described [ 9 ].

Techniques:

Journal: International Journal of Molecular Sciences

Article Title: Opuntia humifusa Supplementation Increased Bone Density by Regulating Parathyroid Hormone and Osteocalcin in Male Growing Rats

doi: 10.3390/ijms13066747

Figure Lengend Snippet: The effect of O. humifusa supplementation on bone mineral density. The data were expressed as the mean ± SE. ( A ) Femur, ( B ) Tibia. CG: Control diet group; EG: Experimental diet group. * p < 0.05 compared with the CG.

Article Snippet: The bone weight was measured using an AR-2140 analytical balance (OHAUS Corporation, NJ, USA), and the BMD and BMC of the femur and tibia were measured with dual-energy X-ray absorptiometry (DEXA, Lunar DPXL, software version 1.0C; Madison, WI, USA).

Techniques: Control

Journal: International Journal of Molecular Sciences

Article Title: Opuntia humifusa Supplementation Increased Bone Density by Regulating Parathyroid Hormone and Osteocalcin in Male Growing Rats

doi: 10.3390/ijms13066747

Figure Lengend Snippet: The effect of O. humifusa supplementation on bone mineral content. The data were expressed as the mean ± SE. ( A ) Femur, ( B ) Tibia. CG: Control diet group; EG: Experimental diet group. ** p < 0.01 compared with the CG.

Article Snippet: The bone weight was measured using an AR-2140 analytical balance (OHAUS Corporation, NJ, USA), and the BMD and BMC of the femur and tibia were measured with dual-energy X-ray absorptiometry (DEXA, Lunar DPXL, software version 1.0C; Madison, WI, USA).

Techniques: Control

Journal: Journal of the American College of Nutrition

Article Title: Dietary Pattern and Bone Density Changes in Elderly Women: A Longitudinal Study

doi:

Figure Lengend Snippet: Comparison of Bone Mineral Density (BMD) at Baseline and Follow-Up

Article Snippet: BMD was estimated using peripheral quantitative computed tomography (pQCT) using an XCT 2000 device (Stratec Medizin-technik, Pforzheim, Germany).

Techniques: Comparison

Journal: Journal of the American College of Nutrition

Article Title: Dietary Pattern and Bone Density Changes in Elderly Women: A Longitudinal Study

doi:

Figure Lengend Snippet: Multivariable Analysis: Odds Ratios for Higher Bone Mineral Density (BMD) Loss *

Article Snippet: BMD was estimated using peripheral quantitative computed tomography (pQCT) using an XCT 2000 device (Stratec Medizin-technik, Pforzheim, Germany).

Techniques: Activity Assay

Journal: Canadian Family Physician

Article Title: Bone mineral density testing after fragility fracture

doi:

Figure Lengend Snippet: Proportion of participants with normal BMD, mild bone loss, and severe bone loss in each of 20 studies: Horizontal bar represents cumulative percent to 100% of BMD test results reported in that study. Black line represents the most conservative cutoff delineating low bone density (69%) from normal bone density (31%).

Article Snippet: AUTHOR, YEAR COUNTRY SETTING NO. OF BMD TEST RESULTS BMD TEST RESULTS 2 OR MORE SELECTION FACTORS OF POTENTIAL INFLUENCE * NORMAL, % OSTEOPENIA, % OSTEOPOROSIS, % 1 Schmid et al, 30 2004 Switzerland Outpatient fracture clinic 29 0 28 72 2 Sidwell et al, 31 2004 New Zealand Orthogeriatric rehabilitation ward 158 4 17 79 3 Becker et al, 29 2006 United States Orthopedic and rehabilitation inpatient wards 61 7 23 70 4 Hegeman et al, 32 2005 The Netherlands Outpatient fracture clinic 100 13 20 67 5 Astrand et al, 33 2006 Sweden Emergency department and orthopedic inpatient ward 239 13 45 42 X 6 Mulherin et al, 34 2003 United Kingdom Emergency department 91 14 34 52 7 Chevalley et al, 35 2002 Switzerland Orthopedic inpatient ward and outpatient clinic 242 14 45 41 8 Hegeman et al, 36 2004 The Netherlands Departments of surgery and traumatology 94 15 34 51 9 Levasseur et al, 37 2007 France Orthopedic inpatient ward 32 16 50 34 10 Rozental et al, 28 2008 United States Orthopedic outpatient clinic 32 16 50 34 X 11 Gallacher, 38 2005 United Kingdom Orthopedic and trauma departments NR 17 46 37 12 Harrington et al, 39 2005 United States Orthopedic inpatient ward and outpatient clinic 154 18 50 32 13 McLellan et al, 26 2003 United Kingdom Emergency department, orthopedic inpatient ward, and fracture clinic 2077 18 42 40 14 van Helden et al, 27 2008 The Netherlands Emergency department and orthopedic inpatient ward 568 21 44 35 X 15 Majumdar et al, 40 2007 Canada Orthopedic surgery department 120 21 34 45 16 Harrington and Lease, 41 2007 United States Orthopedic inpatient ward and outpatient clinic 232 2 57 21 17 Kuo et al, 42 2007 Australia Outpatient fracture clinic 135 24 46 30 X 18 Majumdar et al, 43 2008 Canada Emergency and fracture clinics 95 28 52 20 X 19 Cuddihy et al, 44 2004 United States Orthopedic inpatient ward and outpatient clinic 42 29 50 21 X 20 Majumdar et al, 45 2004 Canada Emergency department 42 31 17 52 Open in a separate window BMD—bone mineral density, NR—not reported.

Techniques:

Journal: The Journal of Clinical Investigation

Article Title: DGAT1-dependent triacylglycerol storage by macrophages protects mice from diet-induced insulin resistance and inflammation

doi: 10.1172/JCI36066

Figure Lengend Snippet: (A) Dgat1 mRNA levels are increased by PPARγ agonists in cultured BMD-Mϕ (n = 3–4 per group). BMD-Mϕ were incubated in medium alone (control) or treated for 24 hours with PPARα agonist (10 μM WY 14643) or PPARγ agonists (10 or 100 μM troglitazone [Trog] or 10 μM pioglitazone [Pio]) as indicated (*P < 0.05). (B) PPARγ activation suppresses M1 response to palmitate treatment in macrophages of WT but not Dgat1–/– mice. mRNA levels in BMD-Mϕ (n = 6–7 per group) incubated in medium alone (control) or with either 150 μM palmitate or the combination of 150 μM palmitate and 10 μM pioglitazone were measured by qPCR (*P < 0.05 vs control, **P < 0.05 vs palmitate). (C) PPARγ activation suppresses cytokine secretion from WT but not Dgat1–/– BMD-Mϕ treated with palmitate (*P < 0.05 vs control; **P < 0.05 vs palmitate).

Article Snippet: BMD-Mϕ cultured in 12-well plates (BD Falcon) were incubated in DMEM plus FBS alone or in medium containing either 200 μM oleate or 150 μM palmitate (both from Sigma-Aldrich).

Techniques: Cell Culture, Incubation, Activation Assay